Pembrolizumab plus axitinib for metastatic papillary and chromophobe kidney cancer
Non-clear cell kidney cancer is a group of different subtypes [...]
Non-clear cell kidney cancer is a group of different subtypes [...]
In this study, real world data is used to compare [...]
A recent paper published in The Oncologist has shown that [...]
At the 2023 Society of Urologic Oncology (SUO) Annual Meeting, [...]
BioNTech, the company who developed the COVID-19 mRNA vaccine, is [...]
Over 400,000 people are diagnosed with kidney cancer globally each [...]
The National Institute for Health and Care Excellence (NICE) has [...]
Immunotherapy medicines have dramatically changed the way advanced (metastatic) kidney [...]
This study looked at real world information from patients with [...]
This phase 2 study looked at the effect on survival [...]